TSS
CMND icon

Two Sigma Securities’s Clearmind Medicine CMND Stock Holding History

Two Sigma Securities’s Portfolio CMND Stock Details CMND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35
Closed -$14.4K – 1582
2025
Q1 		$14.4K Buy
+35
New +$18.3K ﹤0.01% 1164
2023
Q3 		– Sell
-1
Closed -$5.87K – 3002
2023
Q2 		$5.87K Buy
+1
New +$6.75K ﹤0.01% 2657

Other funds holding CMND

GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
CWG
Cornerstone Wealth Group Huntersville, North Carolina $1.69B AUM 28.24% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Two Sigma Securities's CMND Position: Q2 2025 in Review

Two Sigma Securities sold out of Clearmind Medicine (CMND) in Q2 2025, closing a stake of 35 shares — an estimated $14.4K sold.

Two Sigma Securities first reported a position in CMND in Q2 2023 and held it in 2 quarters. The position peaked at $14.4K in Q1 2025. 9 funds tracked by Wall St. Rank hold CMND as of Q2 2025.

  • Two Sigma Securities reported no remaining Clearmind Medicine position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 35 Clearmind Medicine shares in Q2 2025, an estimated $14.4K.
  • Two Sigma Securities first reported a position in Clearmind Medicine in Q2 2023 and held it in 2 quarters.
  • Two Sigma Securities's Clearmind Medicine position peaked at $14.4K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Clearmind Medicine as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.